Clostridium difficile infection in the twenty-first century

被引:78
作者
Ghose, Chandrabali [1 ]
机构
[1] Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA
关键词
B1/NAP1/027; Clostridium difficile; fecal bacteriotherapy; monoclonal antibody; spore; toxin; vaccine; ANTIBIOTIC-ASSOCIATED DIARRHEA; TOXIN-B; SURFACE-PROTEINS; RISK-FACTOR; INTESTINAL COLONIZATION; NOSOCOMIAL ACQUISITION; MAJOR METABOLITE; IMMUNE-RESPONSE; FUSION PROTEIN; NORTH-AMERICA;
D O I
10.1038/emi.2013.62
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Clostridium difficile is a spore-forming gram-positive bacillus, and the leading cause of antibiotic-associated nosocomial diarrhea and colitis in the industrialized world. With the emergence of a hypervirulent strain of C. difficile (BI/NAP1/027), the epidemiology of C. difficile infection has rapidly changed in the last decade. C. difficile infection, once thought to be an easy to treat bacterial infection, has evolved into an epidemic that is associated with a high rate of mortality, causing disease in patients thought to be low-risk. In this review, we discuss the changing face of C. difficile infection and the novel treatment and prevention strategies needed to halt this ever growing epidemic.
引用
收藏
页数:8
相关论文
共 123 条
[11]   Using a dog's superior olfactory sensitivity to identify Clostridium difficile in stools and patients: proof of principle study [J].
Bomers, Marije K. ;
van Agtmael, Michiel A. ;
Luik, Hotsche ;
van Veen, Merk C. ;
Vandenbroucke-Grauls, Christina M. J. E. ;
Smulders, Yvo M. .
BMJ-BRITISH MEDICAL JOURNAL, 2012, 345
[12]   Laboratory-Acquired Clostridium difficile Polymerase Chain Reaction Ribotype 027: A New Risk for Laboratory Workers? [J].
Bouza, Emilio ;
Martin, Adoracion ;
Van den Berg, Renata J. ;
Kuijper, Ed J. .
CLINICAL INFECTIOUS DISEASES, 2008, 47 (11) :1493-1494
[13]   Screening for carriage and nosocomial acquisition of Clostridium difficile by culture:: a study of 284 admissions of elderly patients to six general hospitals in Wales [J].
Brazier, JS ;
Fitzgerald, TC ;
Hosein, I ;
Cefai, C ;
Looker, N ;
Walker, M ;
Bushell, AC ;
Rooney, P .
JOURNAL OF HOSPITAL INFECTION, 1999, 43 (04) :317-319
[14]   Clostridium difficile binary toxin (CDT) and diarrhea [J].
Carman, Robert J. ;
Stevens, Adam L. ;
Lyerly, Matthew W. ;
Hiltonsmith, Megan F. ;
Stiles, Bradley G. ;
Wilkins, Tracy D. .
ANAEROBE, 2011, 17 (04) :161-165
[15]   APPLICATIONS OF NEXT-GENERATION SEQUENCING The human microbiome: at the interface of health and disease [J].
Cho, Ilseung ;
Blaser, Martin J. .
NATURE REVIEWS GENETICS, 2012, 13 (04) :260-270
[16]   Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread [J].
Clements, Archie C. A. ;
Magalhaes, Ricardo J. Soares ;
Tatem, Andrew J. ;
Paterson, David L. ;
Riley, Thomas V. .
LANCET INFECTIOUS DISEASES, 2010, 10 (06) :395-404
[17]   Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial [J].
Cornely, Oliver A. ;
Crook, Derrick W. ;
Esposito, Roberto ;
Poirier, Andre ;
Somero, Michael S. ;
Weiss, Karl ;
Sears, Pamela ;
Gorbach, Sherwood .
LANCET INFECTIOUS DISEASES, 2012, 12 (04) :281-289
[18]   High Frequency of Rifampin Resistance Identified in an Epidemic Clostridium difficile Clone from a Large Teaching Hospital [J].
Curry, Scott R. ;
Marsh, Jane W. ;
Shutt, Kathleen A. ;
Muto, Carlene A. ;
O'Leary, Mary M. ;
Saul, Melissa I. ;
Pasculle, A. William ;
Harrison, Lee H. .
CLINICAL INFECTIOUS DISEASES, 2009, 48 (04) :425-429
[19]   Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis [J].
D'Souza, AL ;
Rajkumar, C ;
Cooke, J ;
Bulpitt, CJ .
BRITISH MEDICAL JOURNAL, 2002, 324 (7350) :1361-1364
[20]   Hypervirulent Clostridium difficile PCR-Ribotypes Exhibit Resistance to Widely Used Disinfectants [J].
Dawson, Lisa F. ;
Valiente, Esmeralda ;
Donahue, Elizabeth H. ;
Birchenough, George ;
Wren, Brendan W. .
PLOS ONE, 2011, 6 (10)